The BIO International Convention covered a wide range of topics and trends in the biotech industry. Some of the key themes discussed include the growth of companies in the development and early phases of drug development, the importance of data integrity and documentation for regulatory compliance, the use of virtual reality and AI in training and drug development, and the advancements in diagnostic testing and disease treatment. The conversation also touched on the challenges of validating AI and the need for caution in relying blindly on AI decisions. Overall, the convention showcased the evolving nature of the industry and the exciting possibilities for the future.
